Aurobindo Pharma standalone net profit declines 4.15% in the June 2016 quarter
Sales rise 7.65% to Rs 2328.58 crore
Net profit of Aurobindo Pharma declined 4.15% to Rs 391.03 crore in the quarter ended June 2016 as against Rs 407.95 crore during the previous quarter ended June 2015. Sales rose 7.65% to Rs 2328.58 crore in the quarter ended June 2016 as against Rs 2163.14 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales2328.582163.14 8 OPM %24.3327.80 -PBDT573.42606.19 -5 PBT503.02543.04 -7 NP391.03407.95 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 25 2016 | 2:20 PM IST